Lantz Financial LLC Sells 40 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Lantz Financial LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 945 shares of the healthcare conglomerate’s stock after selling 40 shares during the period. Lantz Financial LLC’s holdings in UnitedHealth Group were worth $495,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $26,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $30,000. Finally, Promus Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $32,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently commented on UNH. Wells Fargo & Company lowered their target price on shares of UnitedHealth Group from $677.00 to $351.00 and set an “overweight” rating for the company in a report on Wednesday, May 14th. KeyCorp decreased their price objective on shares of UnitedHealth Group from $575.00 to $450.00 and set an “overweight” rating for the company in a report on Wednesday, May 14th. Mizuho decreased their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a report on Friday, May 16th. HSBC restated a “reduce” rating and set a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Finally, Argus downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. One research analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $441.87.

UnitedHealth Group Price Performance

UNH stock opened at $301.08 on Friday. The firm has a 50 day moving average of $430.87 and a 200-day moving average of $494.23. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The firm has a market capitalization of $273.12 billion, a P/E ratio of 19.42, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the business posted $6.91 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,533 shares of the company’s stock in a transaction on Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director John H. Noseworthy bought 300 shares of the company’s stock in a transaction on Wednesday, May 14th. The shares were bought at an average price of $312.16 per share, with a total value of $93,648.00. Following the completion of the transaction, the director now owns 6,063 shares of the company’s stock, valued at $1,892,626.08. The trade was a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock worth $31,607,768 over the last three months. 0.33% of the stock is owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.